A Study of 1592U89 in HIV-Infected Children

Summary

The purpose of this study is to see if it is safe to give 1592U89 to children (aged 6 months until 14th birthday) with advanced HIV infection who have few treatment options available. The study also examines the effect 1592U89 has on the levels of HIV in the blood.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications